ASX Share rice
Sun 09 Aug 2020 - 01:18:am (Sydney)

CDY Share Price

CELLMID LIMITEDCDYPharmaceuticals, Biotechnology & Life Sciences

CDY Company Information


Cellmid Limited





GIC Industry:


GIC Sub Industry:



55 Clarence Street Sydney NSW Australia 2000


61 2 9221 6830

CEO, MD & Exec. Director:

Ms. Maria Halasz

Chief Exec. Officer of Lyramid Limited:

Dr. Bart Wuurman

Managing Director of Advangen Inc:

Mr. Koichiro Koike

Chief Operating Officer:

Mr. Dominic Burg

Head of R&D:

Dr. Graham Robertson

Company Overview:

Cellmid Limited, a life sciences company, develops and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers Midkine (MK) ELISA Kit, a cancer biomarker, and diagnostic and prognostic tool. It is also developing CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. In addition, the company develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.

CDY Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


CDY CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Inventory:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


CDY Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Income Tax Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


CDY Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:




Total Current Liabilities:


Short-Term Debt:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Long-Term Debt:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


CDY Share Price History

CDY News

02 Apr, 2020
Maria Halasz became the CEO of Cellmid Limited (ASX:CDY) in 2007. This analysis aims first to contrast CEO...
03 Feb, 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...
04 Dec, 2019
Cellmid Limited (ASX:CDY) shareholders should be happy to see the share price up 24% in the last month. But don't envy...